Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
H U Group HoldingsMRCHF -5.78%61 Earnings Yield (Joel Greenblatt) % is 5.91% as of Jun. 2026, which is 65% above its 10-year median of 3.59. GuruFocus rates MRCHF with a GF Score™ of 61/100 and a GF Value™ of $17.16 (Modestly Overvalued). The stock has 8 warning signs investors should review. Among 212 Medical Diagnostics & Research companies, H U Group Holdings ranks better than 82.55% on this metric.
H U Group Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was $1,283 Mil.
H U Group Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 was $79 Mil. H U Group Holdings's Earnings Yield (Joel Greenblatt) for the quarter that ended in Jun. 2026 was 5.91%.
The historical rank and industry rank for H U Group Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
MRCHF'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -7.11 Med: 3.59 Max: 23.9
Current: 5.86
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of H U Group Holdings was 23.90%. The lowest was -7.11%. And the median was 3.59%.
MRCHF's Earnings Yield (Joel Greenblatt) % is ranked better than 82.55% of 212
companies
in the Medical Diagnostics & Research industry
Industry Median: -0.035
vs MRCHF: 5.86
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. H U Group Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in Jun. 2026 was -10.89%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
H U Group Holdings (OTCPK:MRCHF) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
H U Group Holdings Earnings Yield (Joel Greenblatt) % Related Terms
H U Group Holdings Earnings Yield (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for H U Group Holdings's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
H U Group Holdings Earnings Yield (Joel Greenblatt) % Chart
For the Diagnostics & Research subindustry, H U Group Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
H U Group Holdings Earnings Yield (Joel Greenblatt) % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, H U Group Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where H U Group Holdings's Earnings Yield (Joel Greenblatt) % falls into.
H U Group Holdings Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
H U Group Holdingss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Mar. 2026 is calculated as
H U Group Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $79 Mil.
What does a Earnings Yield (Joel Greenblatt) % of 5.91% mean?
H U Group Holdings (MRCHF) has a Earnings Yield (Joel Greenblatt) % of 5.91% as of Jun. 2026. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on H U Group Holdings and its competitors. This is 65% above median its historical median of 3.59. According to the industry distribution chart, H U Group Holdings ranks #37 out of 212 companies in the Medical Diagnostics & Research industry, placing it in the top 17.5%.
Is H U Group Holdings' Earnings Yield (Joel Greenblatt) % too high?
H U Group Holdings' current Earnings Yield (Joel Greenblatt) % of 5.91% is 65% above median its 10-year median of 3.59. Based on the distribution chart, H U Group Holdings ranks #37 out of 212 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, H U Group Holdings has a GF Score™ of 61/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does H U Group Holdings' Earnings Yield (Joel Greenblatt) % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, H U Group Holdings ranks #37 out of 212 companies for Earnings Yield (Joel Greenblatt) %. This places H U Group Holdings in the top 18% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings Yield (Joel Greenblatt) % for a Medical Diagnostics & Research company?
A good Earnings Yield (Joel Greenblatt) % depends on the Medical Diagnostics & Research industry context. However, Earnings Yield (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings Yield (Joel Greenblatt) % mean?
A high Earnings Yield (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's earnings yield equals the ratio of earnings before interest and taxes to enterprise value. View historical data on H U Group Holdings and its competitors. H U Group Holdings's current Earnings Yield (Joel Greenblatt) % is 5.91%, which is 65% above median its own 10-year median of 3.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is H U Group Holdings stock overvalued right now?
Based on GuruFocus' analysis, H U Group Holdings (MRCHF) is currently considered Modestly Overvalued. The stock's GF Value™ is $17.16, compared to a current price of $22.00 — trading 28.2% above its estimated fair value. The current Earnings Yield (Joel Greenblatt) % is 5.91%, which is 65% above median its 10-year median of 3.59. H U Group Holdings' overall GF Score™ is 61/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings Yield (Joel Greenblatt) % calculated?
Earnings Yield (Joel Greenblatt) % is calculated from a company's financial statements. For H U Group Holdings (MRCHF), the current Earnings Yield (Joel Greenblatt) % is 5.91% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is H U Group Holdings (MRCHF) Overvalued in 2026?
Based on GuruFocus' analysis, H U Group Holdings stock appears to be overvalued.
The current stock price of $22.00 is trading 28.2% above its estimated GF Value™ of $17.16.
GuruFocus considers H U Group Holdings to be Modestly Overvalued.
Key valuation signals for MRCHF:
Earnings Yield (Joel Greenblatt) %: 5.91% (65% above median its 10-year median of 3.59)
GF Value™: $17.16 vs. price of $22.00 (28.2% above fair value)
No single metric tells the full story. See the MRCHF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
H U Group Holdings Inc operates in the healthcare field, focusing on clinical laboratory testing and reagents. The company is engaged in four main businesses. The Clinical Laboratory Testing Business receives samples taken from patients at medical institutions to test for the disease and confirm the condition of the patient's health; In Vitro Diagnostics develops, manufactures, and sells testing reagents and equipment inside and outside Japan; Sterilization & Related Services Business provides a range of medical-related services including sterilization; and Emerging New Business & Others is a new business for future growth.
61GF Score
Get the complete analysis for MRCHF
Earnings Yield (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MRCHF has been successfully added to your 
